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Protein tyrosine phosphatases (PTPases) have been suggested
to modulate the insulin receptor signal transduction pathways. We
studied PTPases in Psammomys obesus, an animal model of nu-
tritionally induced insulin resistance. No changes in the protein
expression level of src homology PTPase 2 (SHP-2) (muscle, liver)
or leukocyte antigen receptor (LAR) (liver) were detected. In con-
trast, the expression level of PTPase 1B (PTP 1B) in the skeletal
muscle, but not in liver, was increased by 83% in the diabetic ani-
mals, compared with a diabetes-resistant line. However, PTP 1B–
speciﬁc activity (activity/protein) signiﬁcantly decreased (50% to
56%) in skeletal muscle of diabetic animals, compared with both
thediabetes-resistantlineanddiabetes-proneanimals.Inaddition,
PTP 1B activity was inversely correlated to serum glucose level
(r =¡.434, P <.02). These ﬁndings suggest that PTP 1B, though
overexpressed, is not involved in the susceptibility to insulin re-
sistance in Psammomys obesus and is secondarily attenuated by
hyperglycemia or other factors in the diabetic milieu.
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The desert gerbil Psammomys obesus (also known as sand
rat) is an animal model of insulin resistance and nutritionally
induced diabetes. There is no evidence of hyperglycemia or hy-
perinsulinemia in animals freshly trapped in their native habitat,
where they subsist on a meagre herbivorous diet [1]. The an-
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imals remain nondiabetic in captivity when fed a low-energy
(LE) diet containing 2.4 cal/g. However, when transferred to
a relatively high-energy (HE) diet of 3.0 cal/g, similar to the
regular rodent chow, they gradually develop hyperinsulinemia
and hyperglycemia. In Psammomys, the transition to diabetes
have been classiﬁed into 4 consecutive stages [2]: stage A, char-
acterized by normoinsulinemia and normoglycemia; stage B,
showing hyperinsulinemia without hyperglycemia; stage C, as-
sociated with hyperinsulinemia and hyperglycemia; and stage
D, representing the terminal stage with hypoinsulinemia and
hyperglycemia, which is marked by pancreatic insulin secretion
collapse, with apoptosis [3] and dependence on external insulin
supply for survival. A certain percentage of the animals do not
become diabetic even on a HE diet. Selective breeding resulted
in the separation into a diabetes-resistant (DR) line [4], which
remains normoglycemic and normoinsulinemic even on a HE
diet, and a diabetes-prone (DP) line, which is highly suscepti-
ble to diabetes when placed on a HE diet. The hyperglycemia
and hyperinsulinemia induced by the HE diet are associated
with a decreased tyrosine phosphorylation of insulin receptors
(IRs) in liver and muscle and a reduced activity of the IR tyro-
sine kinase (IR-TK) [5]. Both insulin resistance and impaired
tyrosine phosphorylation are reversed upon restriction of food
intake [5].
TheIR-TKactivityisregulatedthroughautophosphorylation
oftyrosineresidues[6,7],dephosphorylationbyproteintyrosine
phosphatases (PTPases) [8, 9], and inhibitory serine/threonine
phosphorylation [10, 11]. Thus, the reason for the attenuation
of insulin signaling in Psammomys could be enhanced PTPase
activity and/or increased activity of serine/threonine kinases.
The latter possibility was conﬁrmed in a recent study in which
we found that protein kinase C" (PKC") and several other PKC
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isoforms were overexpressed and activated in the skeletal mus-
cle of diabetic Psammomys [12]. The overexpression of PKC"
preceded the onset of hyperinsulinemia and hyperglycemia [12]
and could thus be associated with the susceptibility of the ani-
mals to insulin resistance.
The aim of our study was to clarify whether alterations in the
protein expression level or activity of PTPases could contribute
to the development or progression of insulin resistance through
dephosphorylation of IR-TK and other components of the sig-
naling pathway. Several PTPases have been found to play a
crucial role in regulating insulin signal transduction. Studies
in cell models have shown that the leukocyte antigen recep-
tor (LAR) phosphatase, the leukocyte common antigen–related
phosphatase(LRP),andPTPase1B(PTP1B)canactasnegative
regulators of IR-TK, whereas src homology PTPase 2 (SHP-2)
appearstobeapositivemediator-ofinsulinsignaling[9,13–16].
The observation that PTP 1B–deﬁcient mice showed increased
insulin sensitivity and resistance to the development of obe-
sity [17, 18] indicated the possibility of a physiological role
for PTP 1B in the negative regulation of insulin action, which
had been described previously in a number of in vitro studies
[13, 19].
MATERIALS
Human insulin was provided by Novo Nordisk A/S,
Denmark. Protein A sepharose was from Pharmacia Biotech
(Sweden). Wheat germ agglutinin (WGA) agarose was from
Vector Laboratories (Burlingame, CA). [°-32P]ATP (3000 Ci/
mmol)wasfromAmersham(UK).Mousemonoclonalantibody
againstPTP1B(Ab-1)waspurchasedfromOncogeneResearch
Products (Cambridge, MA). Rabbit polyclonal SHP-2 antibody
and normal mouse immunoglobulin G (IgG) were from Santa
Cruz Biotechnology (Santa Cruz, CA). Mouse anti-LAR anti-
body was from Transduction Laboratories (Lexington, KY).
Horseradish peroxidase–conjugated anti-mouse and anti-rabbit
IgG were purchased from Amersham. The cDNA for the type A
IR [20] was cloned into a cytomegalovirus promotor-enhancer–
driven expression vector.
Experimental Animals and Dietary Treatment
Male and female Psammomys obesus from the DP and DR
lines were bred at the Hebrew University Hadassah Medical
School Animal Farm. The animals were weaned at 3 weeks of
age to a LE or HE diet (2.38 and 2.93 cal/g, respectively) man-
ufactured by Koffolk, Petach Tikva, Israel. Psammomys were
housed in individual polypropylene cages, water and food be-
ing supplied ad libitum. All experimental procedures performed
in this study were authorized by the Institutional Animal Care
Committee.
METHODS
Tissue and Blood Collection
Theanimalswerekilledbydecapitationinthefedstateinthe
morning. Blood was collected for the determination of serum
glucose and triglycerides by enzymatic methods (Roche, Basel,
Switzerland) and serum insulin by radioimmunoassay, utiliz-
ing anti-human antibodies (Medgenix, Brussels, Belgium). The
liverandgastrocnemiusmusclefrombothlegswereexcisedand
immediately frozen in liquid nitrogen, then stored at ¡80±C.
Preparation of Lysates
Muscle and liver tissues were extracted in ice-cold homog-
enization buffer I (ﬁnal concentrations: 20 mM Tris-Acetate,
pH 7.0, 0.27 M sucrose, 1 mM EDTA, 1 mM EGTA, 1 mM
4(aminoethyl)benzenesulphonylﬂuoride(AEBSF),0.5%Triton
X-100, 1 mM benzamidine, 1 mM dithiothreitol (DTT), and
4 ¹g/mL leupeptin) using a Polytron. After 20 minutes at 4±C,
the samples were centrifuged at 20,000£g for 60 minutes to
remove insoluble material and the clariﬁed extracts were stored
at ¡80±C.
Subcellular Fractionation
Approximately 200 mg of powdered muscle was homoge-
nizedin2mLofhomogenizationbufferII(20mMTris-Acetate,
pH 7.0, 0.27 M sucrose, 1 mM EDTA, 1 mM EGTA, 1 mM
AEBSF, 1 mM benzamidine, 1 mM DTT, and 4 ¹g/mL leu-
peptin) using a Polytron. Samples were maintained on ice dur-
ing subsequent steps and all centrifugations were performed
at 4±C. The crude homogenate was centrifuged at 700£g for
10 minutes, and the resultant supernatant was centrifuged at
183,000£g for 60 minutes. The supernatant was obtained and
designated as the cytosolic fraction. The pellet was solubilized
inbufferIfor30minutesandwascentrifugedat183,000£g for
60 minutes to obtain solubilized membrane fraction. The pro-
teinconcentrationwasdeterminedusingthemethodofBradford
(BioRad protein assay, BioRad Laboratories, Richmond, CA),
and the tissue fractions were diluted to 1 mg/mI and then stored
at ¡80±C.
Western Blotting, Enhanced Chemical
Luminescence, and Quantiﬁcation of the Bands
Equal amounts of tissue homogenates (40 ¹g/sample) were
dissolved in 2£Laemmli buffer and subject to sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS-PAGE). The
proteins were transferred to nitrocellulose membranes (BA85,
Schleicher & Sch¨ ull, Dassel, Germany). Immunoreactive pro-
teins were made visible using horseradish peroxidase–coupled
secondary antibodies and enhanced chemiluminescence (ECL)
reagents according to the manufacturer’s (Amersham) instruc-
tions.ThespeciﬁcbandswerequantiﬁedusingImageQuantsoft-
ware (Molecular Dynamics, Sunnyvale, CA).PROTEIN TYROSINE PHOSPHATASE 1B IN PSAMMOMYS OBESUS 207
Cell Culture, Transfection, and Transient
Expression of Human Insulin Receptors
Human embryonic kidney ﬁbroblasts (HEK293; ATTC CRL
1573, ATCC, Rockville, MD) were cultured in Dulbecco’s
modiﬁed Eagles medium supplemented with 10% (v/v) fe-
tal bovine serum (Life Technologies, Eggestein, Germany),
10 mg/mL streptomycin, and 100 U/mL penicillin at 37±Ci na
5% CO2-enriched, humidiﬁed atmosphere. The cells were tran-
siently transfected with IR expression plasmid using CaCl2 as
previously described by Chen and Okayama [21] and Gorman
and coworkers [22]. Twenty-four hours after transfection, the
cells were starved overnight in medium containing 5 mM glu-
cose and 0.5% fetal bovine serum.
Cell Lysis and Preparation of Phosphorylated
Insulin Receptors
HEK293 cells overexpressing IRs were homogenized in ly-
sis buffer I containing 20 mM Hepes buffer pH 7.5, 150 mM
NaCl, 10% glycerol, 1.5 mM MgCl2,4m ME G T A ,1m M
EDTA, 1% Triton X-100, 1 mM AEBSF, 30 mM Na 2P2O4,
100 mM Na 3VO4, 10 mM NaF, 5 ug/ml leupeptin and 10 mM
benzamidine. Cellular debris was removed by centrifugation
at 15,000£g for 10 minutes at 4±C. IRs were puriﬁed by
wheat germ agglutinin chromatography of the cell lysates.
Aliquots of 120 ¹g protein of partially puriﬁed IRs were au-
tophosphorylated in a reaction containing 1 ¹M insulin, 5 mM
FIGURE 1
Speciﬁcity of mouse monoclonal antibody toward PTP 1B and its efﬁciency for immunoprecipitation. Muscle homogenates were
incubated with anti–PTP 1B antibody, then precipitated with protein A sepharose. The supernatants (40 ¹g protein) were
subjected to 10% SDS-PAGE and probed with anti–PTP 1B antibody. Equal amounts of total homogenates were also subjected to
the gel to investigate the efﬁciency for immunoprecipitation of this antibody. The membrane was reprobed with anti–SHP-2
antibody as an endogenous control. (a), (d) are from the diabetes-resistant (DR) line; (b), (e) are from the diabetes-prone (DP)
line, stage A; and (c), (f) are from the diabetes-prone (DP) line, stage C. I.P.: immunoprecipitation.
MnCl2, 100 ¹M ATP, 180 ¹Ci/tube of [°-32P]ATP, and 0.1%
Triton X-100 in 50 mM Hepes buffer, pH 7.6, at 4±C for
120 minutes. Unincorporated [°-32P]ATP was removed using
rapid gel on a small Sephadex G-25 column equilibrated in re-
action buffer containing 50 mM Hepes, pH 7.6, 1 mM DTT, and
2 mM EDTA.
Measurements of Tissue PTPase Activity
Aliquots of the labeled receptors (2 ¹g/sample) were in-
cubated with 40 ¹g protein of the samples in the reaction
buffer at 30±C for 20 minutes. The reactions were terminated
by adding 5£ Laemmli buffer and boiling the samples at 100±C
for 2 minutes. The samples were subjected to SDS-PAGE. De-
phosphorylationofthe95-kDa¯-subunitoftheIRwasanalyzed
using PhosphorImager (Molecular Dynamics).
Measurement of PTP 1B Activity
PTP 1B activity was determined by immunoprecipitation us-
ing the antibody against PTP 1B catalytic domain. Aliquots of
tissue homogenates (400 ¹g) were incubated with 2 ¹g of anti–
PTP 1B antibody or normal mouse IgG (as control) at 4±C for
120 minutes. The complexes were precipitated by incubation
with protein A sepharose for 120 minutes. After centrifugation
at 15,000£g for 2 minutes, PTPase activity in the supernatants
was measured as described above. Figure 1 shows the efﬁciency
for immunoprecipitation with this antibody, which resulted in208 Y. IKEDA ET AL.
TABLE 1
Animal characteristics
Animal/stage Weight Maintenance Serum glucose Insulin
(n) (g) diet (mmol/L) (pmol/L)
DR (9) 207§8¤¤¤ HE 5.0§0.3¤¤ 947§158¤
DP/A (11) 151§5 LE 4.1§0.2 581§65
DP/C (10) 201§7¤¤¤ HE 14.7§1.1¤¤¤;z 2497§352¤¤¤;z
Note. The table summarizes weight and serum glucose and insulin levels in the 3
different groups of Psammomys obesus used in this study. The values were obtained in
nonfastinganimals.DR:diabetesresistant;DP/A:diabetes-pronestageA(normoinsuline-
mic, normoglycemic); DP/C: diabetes-prone stage C (hyperinsulinemic, hyperglycemic).
“n” indicates the number of individuals within the group. Values are the mean § SEM.
¤P<.05, ¤¤P<.01, ¤¤¤P<.001 versus DP/A; zP<.001 versus DR.
depletion of 90.7% to 93.7% of PTP 1B expression com-
pared with that in total muscle homogenates. The difference in
PTPase activity between immunodepleted supernatant with
normal mouse IgG and that with anti–PTP 1B was calculated
and deﬁned as PTP 1B activity.
Statistical Analysis
All values are presented as the mean§SEM. Group compar-
isons were made by unpaired Student’s t test. Correlations were
assessed by Pearson’s least squares method. P values less than
.05 were considered signiﬁcant.
RESULTS
Animal Characteristics
The general characteristics of animals used in this study are
summarized in Table 1. DP animals on HE diet (3.0 cal/g)
FIGURE 2
Expression of PTP 1B and SHP-2 in the gastrocnemius muscle. Muscle homogenates (40 ¹g) were subjected to SDS-PAGE and
Western blotting, then probed with SHP-2– or PTP 1B–speciﬁc antibodies. The respective bands were quantitated using
ImageQuant software. The mean value of DR animals was set to 100 and all other values were calculated accordingly. Expression
levels given represent the mean § SEM of 9 to 11 samples. P values were determined using Student’s t test. DR:
diabetes-resistant line; DP/A: diabetes-prone line, stage A (normoinsulinemic, normoglycemic); DP/C: diabetes-prone line,
stage C (hyperinsulinemic, hyperglycemic). ¤P<.05 versus DR.
showed hyperinsulinemia and hyperglycemia. However, DP an-
imals on LE diet (2.4 cal/g) had relatively lower body weights
and glucose and insulin levels than DR animals on HE diet.
Well-deﬁned animals groups (n D9–11 per group) were taken
for the PTPase study.
PTP 1B Overexpression in the Gastrocnemius
Muscle of Diabetic Psammomys obesus
We ﬁrst aimed to determine the protein expression level of
speciﬁc PTPase enzymes (PTP 1B, SHP-2, and LAR) in skele-
tal muscle tissues. Western blots of muscle lysates were probed
with speciﬁc antibodies for these PTPases. An example of such
a Western blot for PTP 1B is shown for a subset of samples
from each group in Figure 1 (tissue lysates a to f). PTP 1B was
detected as a single band at »50 kDa. No bands correspond-
ing to LAR were detected in skeletal muscle, although clearPROTEIN TYROSINE PHOSPHATASE 1B IN PSAMMOMYS OBESUS 209
single bands at »150 kDa were detected in liver homogenates.
Figure2summarizesthequantiﬁcationandstatisticalanalysisof
the speciﬁc bands from all samples analyzed. Expression levels
of PTP 1B were signiﬁcantly increased in the diabetic animals
(DP/C) compared with the DR line (82.9% increase), and the
increase was also observed in the prediabetic animals (DP/A),
but not signiﬁcantly so. There was no signiﬁcant difference in
SHP-2 expression between healthy and diabetic animals (data
not shown).
Total PTPase Activity
Because PTP 1B was overexpressed in skeletal muscle
of diabetic Psammomys, we determined the PTPase activity
in each group. The enzyme activity, measured using IR as
a substrate, was surprisingly decreased in diabetic animals
(DP/C) compared with DR (27.5% decrease) or DP/A ani-
mals (22.5% decrease) (Figure 3a). We also measured the
PTPase activity in subcellular fractions and found that this de-
crease was mainly due to the decrease in the particulate fraction
(DRD100.0§12.8; DP/AD93.7§5.9; DP/CD51.9§13.6
[arbitrary units], P<.05).
We further investigated whether the decrease in the over-
all PTPase activity in diabetic animals was associated with a
change in PTP 1B activity. PTP 1B activity was calculated
as total PTPase activity minus PTPase activity after depletion
FIGURE 3
PTPase activity in the gastrocnemius muscle. (a) Total PTPase activity in muscle homogenates was measured as described in
Methods, using autophosphorylated insulin receptor as the substrate. Dephosphorylation of the 95-kDa ¯-subunit of the insulin
receptor was analyzed by PhosphorImager (Molecular Dynamics). (b) Muscle homogenates were precipitated with anti–PTP 1B
antibody or normal mouse IgG (control) and protein A sepharose. PTPase activities in the supernatants were measured and the
difference in the enzyme activity between 2 samples was calculated and designated as the PTP 1B activity. (c) PTP 1B activities
in muscle homogenates were divided by its expression in the individual samples to reﬂect the enzyme activity per molecule. The
mean value of total PTPase activity in DR animals was set to 100 and all other values were calculated accordingly. Data represent
the mean§SEM of 9 to 11 samples for (a) and 8 to 10 samples for (b), (c). P values were determined using Student’s t test. DR:
diabetes-resistant line; DP/A: diabetes-prone line, stage A (normoinsulinemic, normoglycemic); and DP/C: diabetes-prone line,
stage C (hyperinsulinemic, hyperglycemic). ¤P<.05, ¤¤P<.01 versus DR; yP<.05,
zP<.01 versus DP/A.
with a PTP 1B–speciﬁc antibody. In addition to the decrease in
total PTPase activity, we detected also a decrease in PTP 1B
activity in muscle homogenates of diabetic animals (Figure 3b).
PTP 1B activity in the particulate fraction was decreased to
60% in diabetic animals when compared with DR or DP/A ani-
mals (DRD53.5§6.7; DP/AD53.5§5.3; DP/CD32.3§5.6
[arbitrary units], P <.05). However the decrease was not sig-
niﬁcant when compared with DR animals. The ratio between
protein expression and activity, which could reﬂect the enzyme
activity per molecule, was markedly decreased in diabetic ani-
mals (0.23§0.05) compared with both DR and DP/A animals
(0.52§0.12and0.45§0.09,respectively)(Figure3c),suggest-
ing attenuation of this molecule by the diabetic milieu. There
was an inverse correlation between PTP 1B activity in skeletal
muscle and serum glucose concentration (r D¡.434, P <.02).
There was also an inverse relationship between total PTPase
activity in skeletal muscle and serum glucose concentration
(r D¡.625, P <.001) (Figure 4).
Total Liver PTPase Activity
WealsoexaminedPTPaseexpressionandactivityinliverho-
mogenates (n D9–10 per group). No signiﬁcant differences in
the expression levels of LAR, SHP-2, or PTP 1B in the 3 groups
of animals were detected (data not shown). In these sam-
ples, total PTPase activity in diabetic animals was signiﬁcantly210 Y. IKEDA ET AL.
FIGURE 4
Correlation between PTPase activity in skeletal muscle and serum glucose concentrations. The activities of total PTPase and
PTP 1B were determined as described in Methods and the correlations in the individual Psammomys samples (n D29) are
plotted. Correlation coefﬁcients (r) and P values are indicated.
lower compared with that in DR and DP/A animals (DRD
100.0§3.9; DP/AD106.5§4.1; DP/CD82.5§1.9 [arbitrary
units], P <.001). There was no signiﬁcant difference in
PTP 1B activity (DRD38.0§1.7; DP/AD42.5§1.6; DP/CD
37.8§1.9 [arbitrary units]).
DISCUSSION
PTP 1B has been associated with insulin resistance in differ-
ent cell models [23–26]. Some studies have reported the inﬂu-
ence of hyperinsulinemia or hyperglycemia on PTP 1B content
or PTPase activity in vitro [27, 28]. Kenner and colleagues [27]
showed that insulin increased particulate PTPase activity and
PTP 1B mRNA and protein in rat L6 skeletal muscle cells. Ide
and coworkers [28] reported that D-glucose increased cytoso-
lic PTPase activity and PTP 1B content. However, the PTP 1B
expressionlevelorPTPaseactivityininsulin-sensitivetissuesof
insulin-resistant animals or humans is not uniform [29–37] and
the signiﬁcance is unknown. The reported variation of PTPase
activity may be caused by differences in species, tissue, pe-
riod, or level of hyperglycemia. The difference in substrate used
for the PTPase assay may also result in such variation. For ex-
ample, Ahmad and Goldstein [29] demonstrated that the par-
ticulate PTPase activity toward both myelin basic protein and
lysozyme was increased in hindlimb skeletal muscle of insulin-
resistant obese (fa/fa) and diabetic (ZDF/Drt-fa/fa) Zucker rats.
In contrast, Worm and colleagues [35] demonstrated that cy-
tosolic PTPase activity toward immobilized IRs was decreased
inthesoleusmuscleoffa/faZuckerrats,whereastheparticulate
PTPase activity did not change.
We investigated the protein expression level and activity of
PTP 1B in Psammomys obesus, which has the advantage of
being extremely well characterized with respect to the devel-
opment of insulin resistance and diabetes. Our ﬁndings sug-
gest that PTP 1B is overexpressed in the skeletal muscle of
diabetic Psammomys obesus (DP/C), using animals from the
diabetes-resistant line (DR) as a basal reference. This appears
to be a speciﬁc change because expression levels of SHP-2,
a positive regulator of insulin signaling, were not increased.
We measured PTPase activity using whole IR as the substrate.
Impairment of the IR-TK activity in stages B and C has been
shownbefore[5],andwe,therefore,suggestedthatthismightbe
causally related to alterations in PTPase expression or activity.
In contrast to our expectations, we found that PTPase activity
towardautophosphorylatedIRwassigniﬁcantlydecreasedindi-
abetic animals compared with not only the DR animals but also
the diabetes-prone DP/A animals. To assess PTP 1B activity,
we immunoprecipitated using anti-PTP 1B–speciﬁc antibody
and measured PTPase activity in the depleted supernatant. Be-
cause this antibody efﬁciently precipitates PTP 1B from tissue
homogenate, we consider this method suitable for evaluating
PTP 1B activity in these animals. The speciﬁc activity of PTP
1B (activity/protein) was signiﬁcantly decreased in DP/C com-
pared with DR and DP/A animals. The total activity of PTP
1B was signiﬁcantly decreased in DP/C compared with DR and
DP/Aanimals(normoglycemic,normoinsulinemicPsammomys
from the same line). In addition, total PTP 1B activity was de-
creased in the particulate fraction to 60% in DP/C when com-
pared with DR and DP/A animals. These ﬁndings suggest that
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therefore, most likely rules out a role for this PTPase in induc-
tionofinsulinresistancethroughincreaseddephosphorylationof
the IR.
Worm and colleagues [35] reported that skeletal muscle PT-
Pase activity was decreased in diabetic (fa/fa) Zucker rats com-
pared with their lean littermates (Fa/¡). The reduction was
completely prevented by metformin treatment, which decreased
plasma glucose and insulin levels. This appears to concur with
the present observation that the reduction in PTPase activity in
DP animals was fully prevented by dietary restriction, which
kept them normoinsulinemic and normoglycemic. These ﬁnd-
ings suggest that the difference in PTP 1B activity in skeletal
muscle between the diabetic Psammomys and the controls is not
genetic,butasecondarychangetodiabetesmellitus,andthatthe
overexpressionofPTP1Bprobablyresultsfromacompensatory
mechanism.
The inverse correlation between serum levels and PTP 1B
activity (Figure 4, showing lower PTPase activity at higher glu-
cose levels), may be interpreted to be the result of a deleteri-
ous effect of the diabetic milieu on PTP 1B activity. Glycation
and/or oxidative inactivation [38] of the enzyme are probably
detrimental to its activity. We therefore do not believe that the
high glucose levels are attenuating the insulin action through
PTPase activity. Further investigation is required to clarify
this.
Because the liver plays an important role in regulating blood
glucose levels through gluconeogenesis, we also examined the
expression and activity of PTPase in this tissue. However, there
was no difference in expression levels of PTP 1B, SHP-2, or
LAR among the three groups. Total PTPase activity in the
liver was decreased in diabetic animals, but this decrease could
not be explained by reduced PTP 1B enzyme activity. In our
companion article in this issue, Meyerovitch and colleagues
[39] reported that hepatic cytosolic PTPase LAR signiﬁcantly
increased after overnight fasting in nondiabetic Psammomys,
but not in diabetic animals, perhaps due to a regulatory de-
fect. Therefore, a regulatory PTPase defect in the diabetic state
may have a more important impact than an alteration in basal
activity.
In conclusion, we have demonstrated that diabetic
Psammomysobesus(DP/C)exhibitedanimpairedPTP1B(pro-
tein overexpression with decreased activity) in skeletal mus-
cle. This was not detected in DP/A animals from the same
line, which were normoinsulinemic and normoglycemic on a
LE diet. In general, PTP 1B does not appear to be causally re-
lated to the difference in susceptibility to diabetes between the
DR and DP lines, and its activity does not impair IR-TK ac-
tivity in Psammomys obesus. The up-regulated expression of
skeletal muscle PTP 1B may probably be a result of compen-
sation for the attenuated activity in diabetes. Further studies are
required to uncover the mechanism of PTP 1B attenuation in
diabetes.
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